<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Reg Anesth Pain Med</journal-id><journal-id journal-id-type="iso-abbrev">Reg Anesth Pain Med</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Regional anesthesia and pain medicine</journal-title></journal-title-group><issn pub-type="ppub">1098-7339</issn><issn pub-type="epub">1532-8651</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11350632</article-id><article-id pub-id-type="pmcid-ver">PMC11350632.1</article-id><article-id pub-id-type="pmcaid">11350632</article-id><article-id pub-id-type="pmcaiid">11350632</article-id><article-id pub-id-type="manuscript-id">NIHMS1926549</article-id><article-id pub-id-type="pmid">37380198</article-id><article-id pub-id-type="doi">10.1136/rapm-2023-104613</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS1926549</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA1926549</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>A Cohort Study of New Off-label Gabapentin Prescribing in Chronic Opioid Users</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Billig</surname><given-names initials="JI">Jessica I.</given-names></name><degrees>MD, MS</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Bicket</surname><given-names initials="MC">Mark C.</given-names></name><degrees>MD, PhD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yazdanfar</surname><given-names initials="M">Maryam</given-names></name><degrees>MD, MPH, MS</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gunaseelan</surname><given-names initials="V">Vidhya</given-names></name><degrees>MS, MBA, MHA</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sears</surname><given-names initials="ED">Erika D.</given-names></name><degrees>MD, MS</degrees><xref rid="A3" ref-type="aff">c</xref><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Brummett</surname><given-names initials="CM">Chad M.</given-names></name><degrees>MD</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Waljee</surname><given-names initials="JF">Jennifer F.</given-names></name><degrees>MD, MPH, MS</degrees><xref rid="A4" ref-type="aff">d</xref></contrib></contrib-group><aff id="A1"><label>a.</label>Department of Orthopaedic Surgery, Washington University in St. Louis, St. Louis, Missouri</aff><aff id="A2"><label>b.</label>Department of Anesthesiology, Michigan Medicine, Ann Arbor, Michigan</aff><aff id="A3"><label>c.</label>VA Center for Clinical Management Research, VA Ann Arbor Healthcare System</aff><aff id="A4"><label>d.</label>Section of Plastic Surgery, Michigan Medicine, Ann Arbor, Michigan</aff><author-notes><fn fn-type="con" id="FN1"><p id="P34">CONTRIBUTORSHIP</p><p id="P35">Jessica Billig- study design, data analysis, manuscript writing and editor, guarantor</p><p id="P36">Mark C. Bicket- study design, manuscript editing</p><p id="P37">Maryam Yazdanfar- data collection, data analysis, manuscript editing</p><p id="P38">Vidhya Gunaseelan- data collection, data analysis, manuscript editing</p><p id="P39">Erika D. Sears- study design, manuscript editing</p><p id="P40">Chad M. Brummett- study design, manuscript editing</p><p id="P41">Jennifer F. Waljee- study design, data analysis, manuscript writing and editing</p></fn><corresp id="CR1"><bold>Corresponding Author:</bold> Jessica I. Billig, MD, MS, Department of Orthopaedic Surgery, Washington University in St. Louis, 660 Euclid Ave, St. Louis, MO 63110, <email>jibillig@gmail.com</email>, Phone: 314-747-5697, Fax: 314-747-2599</corresp><fn fn-type="COI-statement" id="FN3"><p id="P42"><bold>Conflict of Interest:</bold> Dr. Brummett is a consultant for Heron Therapeutics (San Diego, CA). All other authors have no conflicts of interest.</p></fn></author-notes><pub-date pub-type="epub"><day>05</day><month>2</month><year>2024</year></pub-date><pub-date pub-type="collection"><day>05</day><month>2</month><year>2024</year></pub-date><volume>49</volume><issue>2</issue><issue-id pub-id-type="pmc-issue-id">469462</issue-id><fpage>88</fpage><lpage>93</lpage><pub-history><event event-type="nihms-submitted"><date><day>21</day><month>10</month><year>2023</year></date></event><event event-type="pmc-release"><date><day>28</day><month>08</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>28</day><month>08</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-08-29 09:25:34.903"><day>29</day><month>08</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-1926549.pdf"/><abstract id="ABS1"><sec id="S1"><title>Introduction:</title><p id="P1">Gabapentin is commonly prescribed as an off-label adjunct to opioids because of its safer risk profile. Recent evidence has shown an increased risk of mortality when co-prescribed with opioids. Therefore, we aimed to evaluate whether the addition of off-label gabapentin in patients with chronic opioid use is associated with a reduction in opioid dosage.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We performed a retrospective cohort study of patients with chronic opioid use with a new off-label gabapentin prescription (2010&#8211; 2019). Our primary outcome of interest was a reduction in opioid dosage measured via oral morphine equivalents (OME) per day after the addition of a new off-label gabapentin prescription.</p></sec><sec id="S3"><title>Results:</title><p id="P3">In our cohort of 172,607 patients, a new off-label gabapentin prescription was associated with a decrease in opioid dosage in 67,016 patients (38.8%) (median OME/day reduction:13.8), with no change in opioid dosage in 24,468 patients (14.2%), and an increase in opioid dosage in 81,123 patients (47.0%) (median OME/day increase: 14.3). A history of substance/alcohol use disorders was associated with a decrease in opioid dosage after the addition of a new off-label gabapentin (aOR: 1.20, 95%CI: 1.16&#8211;1.23). A history of pain disorders was associated with a decrease in opioid dosage after the initiation of a new gabapentin prescription including arthritis (aOR: 1.12, 95%CI: 1.09&#8211;1.15), back pain (aOR: 1.10, 95%CI: 1.07&#8211;1.12), and other pain conditions (aOR: 1.08, 95%CI: 1.06&#8211;1.10).</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">In this study of patients with chronic opioid use, an off-label gabapentin prescription did not reduce opioid dosage in the majority of patients. The co-prescribing of these medications should be critically evaluated to ensure optimal patient safety.</p></sec></abstract><kwd-group><kwd>chronic opioid use</kwd><kwd>off-label</kwd><kwd>gabapentin</kwd><kwd>opioids</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>